DAVID POPLACK to Leukocyte Count
This is a "connection" page, showing publications DAVID POPLACK has written about Leukocyte Count.
Connection Strength
0.065
-
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. Cancer Res. 1992 Feb 01; 52(3):521-4.
Score: 0.023
-
Remission induction of meningeal leukemia with high-dose intravenous methotrexate. J Clin Oncol. 1985 Apr; 3(4):485-9.
Score: 0.015
-
Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 1976 Dec; 48(6):809-16.
Score: 0.008
-
Phase I/pharmacokinetic reevaluation of thioTEPA. Cancer Res. 1991 Jun 15; 51(12):3171-6.
Score: 0.006
-
Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol. 1986; 14(3):191-4.
Score: 0.004
-
Phase II study of 5-azacytidine in sarcomas of bone. Am J Clin Oncol. 1982 Aug; 5(4):411-5.
Score: 0.003
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.002
-
Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Gu?rin. Cancer Res. 1978 Apr; 38(4):1049-51.
Score: 0.002
-
Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30; 290(22):1220-3.
Score: 0.002